Information - Huntington's Disease (HD)

Support Services

Haloperidol (Haldol)

Buspirone (Buspar)

Donation Button

AHDA Qld Inc

Buy Buspirone (Buspar) tablets online

How and where to order Buspar (Buspirone Hydrochloride) 5 mg, 10 mg tablets or capsules online:

Shop:DFH PHARMACY - 10% discount coupon DFH10
Prices:from $0.27 per pill
Forms:5 mg, 10 mg tablets
Quantity:30-360 pills
Type:Buspirone brand, Buspar generic
Payment:Visa, Mastercard, AmEx, Cryptocurrencies
Delivery:Regular and express mail service
Shipping:Worldwide, including USA, UK, Europe, Canada, Australia

Indications and usage:

BuSpar (Buspirone Hydrochloride) is indicated for the treatment of:

  • Huntington's disease
  • anxiety disorders
  • generalized anxiety disorder (GAD)
  • the short-term relief of the symptoms of anxiety with or without accompanying depression
  • clinical depression
  • panic disorder
  • attention deficit hyperactivity disorder (ADHD)
  • mild to moderate cerebellar ataxia
  • borderline personality disorder
  • benzodiazepines, barbiturates, alcohol withdrawal
  • delirium tremens
  • bruxism on SSRI/SNRI-induced jaw clenching
  • hypoactive sexual desire disorder (HSDD) in women
  • SSRI induced sexual dysfunction
  • depression and behavioral problems following brain damage
  • some other nervous and anxiety disorders


    BuSpar is contraindicated in patients hypersensitive to buspirone hydrochloride.

    Dosage and administration:

    The recommended initial dose is 15 mg daily (7.5 mg b.i.d.). To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased 5 mg per day, as needed. The maximum daily dosage should not exceed 60 mg per day. In clinical trials allowing dose titration, divided doses of 20 mg to 30 mg per day were commonly employed.

    The bioavailability of buspirone is increased when given with food as compared to the fasted state. Consequently, patients should take buspirone in a consistent manner with regard to the timing of dosing; either always with or always without food.

    Dosage forms and strengths:

    BuSpar (Buspirone Hydrochloride) tablets for oral usage, 5 mg and 10 mg.


    Signs and symptoms

    In clinical pharmacology trials, doses of Buspirone HCl as high as 375 mg/day were administered to healthy male volunteers. As this dose was approached, the following symptoms were observed: nausea, vomiting, dizziness, drowsiness, miosis, and gastric distress. A few cases of overdosage have been reported, with complete recovery as the usual outcome. No deaths have been reported following overdosage with BuSpar alone. Rare cases of intentional overdosage with a fatal outcome were invariably associated with ingestion of multiple drugs and/or alcohol, and a causal relationship to buspirone could not be determined. Toxicology studies of buspirone yielded the following LD50 values: mice, 655 mg/kg; rats, 196 mg/kg; dogs, 586 mg/kg; and monkeys, 356 mg/kg. These dosages are 160 to 550 times the recommended human daily dose.

    Recommended overdose treatment

    General symptomatic and supportive measures should be used along with immediate gastric lavage. Respiration, pulse, and blood pressure should be monitored as in all cases of drug overdosage. No specific antidote is known to buspirone, and dialyzability of buspirone has not been determined.


    The administration of BuSpar to a patient taking a monoamine oxidase inhibitor (MAOI) may pose a hazard. There have been reports of the occurrence of elevated blood pressure when BuSpar (buspirone hydrochloride) has been added to a regimen including an MAOI. Therefore, it is recommended that this drug not be used concomitantly with an MAOI.

    Because buspirone has no established antipsychotic activity, it should not be employed in lieu of appropriate antipsychotic treatment.


  • Interference with cognitive and motor performance.
  • Potential for withdrawal reactions in sedative/hypnotic/anxiolytic drug-dependent patients.
  • Possible concerns related to buspirone's binding to dopamine receptors.

  • Information for patients:

    To assure safe and effective use of BuSpar, the following information and instructions should be given to patients:

  • Inform your physician about any medications, prescription or non-prescription, alcohol, or drugs that you are now taking or plan to take during your treatment with buspirone hydrochloride.
  • Inform your physician if you are pregnant, or if you are planning to become pregnant, or if you become pregnant while you are taking BuSpar.
  • Inform your physician if you are breast-feeding an infant.
  • Until you experience how this medication affects you, do not drive a car or operate potentially dangerous machinery.
  • You should take BuSpar (Buspirone HCl) tablets consistently, either always with or always without food.
  • During your treatment with this medication, avoid drinking large amounts of grapefruit juice.

  • Drug interactions:

    Use buspirone tablets with caution with these products: psychotropic agents (MAO inhibitors, amitriptyline, diazepam, haloperidol, nefazodone, trazodone, triazolam, flurazepam), inhibitors and inducers of CYP3A4 (diltiazem, verapamil, erythromycin, itraconazole, nefazodone, rifampin, ketoconazole, dexamethasone, phenytoin, phenobarbital, carbamazepine, ritonavir, grapefruit juice), cimetidine.

    Adverse reactions, side effects:

    The more commonly observed untoward events associated with the use of buspirone pills not seen at an equivalent incidence among placebo-treated patients include dizziness, nausea, headache, nervousness, lightheadedness, and excitement.

    To report suspected adverse reactions of BuSpar (Buspirone) tablets, contact Bristol-Myers Squibb pharmaceutical company or your local FDA.

    Drug abuse and dependence:

    Controlled substance class

    BuSpar (buspirone hydrochloride) is not a controlled substance in most of countries worldwide.

    Use in specific populations:


    No fertility impairment or fetal damage was observed in reproduction studies performed in rats and rabbits at buspirone doses of approximately 30 times the maximum recommended human dose. In humans, however, adequate and well-controlled studies during pregnancy have not been performed. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

    Labor and delivery

    The effect of BuSpar (buspirone hydrochloride) on labor and delivery in women is unknown. No adverse effects were noted in reproduction studies in rats.

    Nursing mothers

    The extent of the excretion in human milk of buspirone or its metabolites is not known. In rats, however, buspirone and its metabolites are excreted in milk. BuSpar administration to nursing women should be avoided if clinically possible.

    Pediatric use

    The safety and effectiveness of buspirone were evaluated in two placebo-controlled 6-week trials involving a total of 559 pediatric patients (ranging from 6 to 17 years of age) with GAD. Doses studied were 7.5 mg to 30 mg b.i.d. (1560 mg/day). There were no significant differences between buspirone and placebo with regard to the symptoms of GAD following doses recommended for the treatment of GAD in adults. Pharmacokinetic studies have shown that, for identical doses, plasma exposure to buspirone and its active metabolite, 1-PP, are equal to or higher in pediatric patients than adults. No unexpected safety findings were associated with buspirone in these trials. There are no long-term safety or efficacy data in this population.

    Geriatric use

    In one study of 6632 patients who received buspirone for the treatment of anxiety, 605 patients were ?65 years old and 41 were >= 75 years old; the safety and efficacy profiles for these 605 elderly patients (mean age = 70.8 years) were similar to those in the younger population (mean age = 43.3 years). Review of spontaneously reported adverse clinical events has not identified differences between elderly and younger patients, but greater sensitivity of some older patients cannot be ruled out.

    Where to buy buspirone online:

    To purchase Buspar (Buspirone HCl) 5 mg, 10 mg tablets from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.

    Here is a list of popular medications containing buspirone as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
  • Capsules; Oral; Buspirone Hydrochloride 5 mg, 7.5 mg, 10 mg, 15 mg
  • Tablets; Oral; Buspirone Hydrochloride 5 mg, 10 mg, 15 mg, 30 mg
  • Bristol-Myers Squibb
  • Aspen
  • Boryung Pharmaceutical
  • Doncaster Pharmaceuticals Group
  • Landmark Pharma
  • Orion Pharma
  • Buspin
  • Tablets; Oral; Buspirone Hydrochloride 5 mg, 10 mg
  • Intas Pharmaceuticals
  • Buspirone
  • Tablets; Oral; Buspirone Hydrochloride 5 mg, 10 mg, 15 mg, 30 mg
  • Mylan
  • Spitomin
  • Tablets; Oral; Buspirone Hydrochloride 5 mg, 10 mg
  • Egis

  • Copyright © 2001 - 2024 Australian Huntington's Disease Association (Qld) Inc. All rights reserved.